First Allied Advisory Services’s Ionis Pharmaceuticals IONS Stock Holding History

First Allied Advisory Services’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,455	Closed	-$204K	–	1206
2020 Q2	$204K	Buy	+3,455	New	+$192K	0.01%	1000
2020 Q1	–	Sell	-4,332	Closed	-$265K	–	1141
2019 Q4	$265K	Buy	4,332 +38	+0.9%	+$2.26K	0.01%	991
2019 Q3	$252K	Sell	4,294 -166	-4%	-$10.8K	0.01%	987
2019 Q2	$287K	Buy	4,460 +95	+2%	+$6.71K	0.01%	907
2019 Q1	$347K	Sell	4,365 -874	-17%	-$56.4K	0.01%	804
2018 Q4	$282K	Sell	5,239 -173	-3%	-$8.82K	0.01%	805
2018 Q3	$281K	Sell	5,412 -167	-3%	-$7.85K	0.01%	938
2018 Q2	$233K	Buy	5,579 +311	+6%	+$13.8K	0.01%	989
2018 Q1	$228K	Buy	5,268 +433	+9%	+$22K	0.01%	988
2017 Q4	$246K	Sell	4,835 -301	-6%	-$16.5K	0.01%	966
2017 Q3	$259K	Sell	5,136 -327	-6%	-$17.1K	0.01%	885
2017 Q2	$279K	Buy	5,463 +494	+10%	+$23K	0.01%	867
2017 Q1	$200K	Sell	4,969 -28	-0.6%	-$1.26K	0.01%	1001
2016 Q4	$239K	Buy	+4,997	New	+$198K	0.01%	902
2015 Q3	–	Sell	-5,808	Closed	-$335K	–	1093
2015 Q2	$335K	Buy	+5,808	New	+$369K	0.02%	778
2014 Q4	–	Sell	-6,471	Closed	-$250K	–	1071
2014 Q3	$250K	Sell	6,471 -903	-12%	-$32K	0.02%	814
2014 Q2	$247K	Buy	+7,374	New	+$232K	0.02%	792

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

First Allied Advisory Services's IONS Position: Q3 2020 in Review

First Allied Advisory Services sold out of Ionis Pharmaceuticals (IONS) in Q3 2020, closing a stake of 3,455 shares — an estimated $204K sold.

First Allied Advisory Services first reported a position in IONS in Q2 2014 and held it in 17 quarters. The position peaked at $347K in Q1 2019. 367 funds tracked by Wall St. Rank hold IONS as of Q3 2020.

First Allied Advisory Services reported no remaining Ionis Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
First Allied Advisory Services sold 3,455 Ionis Pharmaceuticals shares in Q3 2020, an estimated $204K.
First Allied Advisory Services first reported a position in Ionis Pharmaceuticals in Q2 2014 and held it in 17 quarters.
First Allied Advisory Services's Ionis Pharmaceuticals position peaked at $347K in Q1 2019.
367 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.